Skip to content

MIGRC Logo Michigan Genetics Resource Center

  • Home
  • Patients & Families
    • Birth Defects Prevention
    • Family Health History
    • Genetic Health Services
    • Hereditary Cancers
    • Michigan BioTrust for Health
    • MI HEARTSafe Schools
    • Newborn Screening
    • Sudden Cardiac Death
  • Providers
    • Birth Defects Prevention
    • Family Health History
    • Hereditary Cancers
    • Michigan Cancer Genetics Alliance
    • Newborn Screening
    • Sudden Cardiac Death
  • Teaching Tools
    • Banana DNA Experiment
    • External Resources
    • Genetic Inheritance Patterns
  • Order Materials
  • Feedback
  • Home
  • Resources
  • PARP Inhibitors for the Treatment of Ovarian Cancer: Rationale and Clinical Outcomes

PARP Inhibitors for the Treatment of Ovarian Cancer: Rationale and Clinical Outcomes

PARP Inhibitors for the Treatment of Ovarian Cancer: Rationale and Clinical Outcomes – Presentation by Dr. Karen McLean at the MCGA Annual Meeting, April 2016.

Download resource
Audience: Providers
Languages: English
Keywords: ovarian cancer hereditary cancer cancer genomics cancer genetics PARP PART inhibitors
  • Home
  • Patients & Families
  • Providers
  • Teaching Tools
© 2018 MIGRC — Feedback